The world’s largest meeting on cancer research has brought promising updates on treatment and prevention for colorectal ...

Abstracts published ahead of the 2025 American Society of Clinical Oncology Annual Meeting found persistent ovarian cancer survival disparities among racial and ethnic subgroups, particularly ...

Reducing the length of immunotherapy treatment for an advanced skin cancer did not significantly diminish disease control ...

Several oral abstracts presented at the American Society of Clinical Oncology’s annual meeting highlight ongoing research of Keytruda, Opdivo, Tecentriq and more in skin cancer.

Primary surgery for advanced ovarian cancer significantly improves progression-free survival but not overall survival ...

Patients who have completed colon cancer treatment could cut their risk of cancer-related death by 37% if they stick to a ...

An anti-inflammatory diet may be beneficial for colon cancer survivors, according to a new clinical trial. People who adhered ...

Patients who have been treated for colon cancer could cut their risk of death by 37% if they stick to a structured exercise ...

Adding immunotherapy to chemotherapy after surgery for stage 3 colon cancer may help decrease recurrence and death rate by 50 ...

Five early-career Fred Hutch/UW researchers received prestigious Young Investigator Awards from Conquer Cancer, the ASCO Foundation during this year's annual meeting of the American Society of ...

New data support the role of structured exercise and low inflammatory diets to improve survival and quality of life following ...

Elinzanetant proved effective for managing disruptive vasomotor symptoms in women on endocrine therapy, supporting a Bayer ...